Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR20.19.22 T-cells for B-cell Malignancies
NCT05094206Phase 1Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2022
- Primary completion
- Jan 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of CAR20.19.22 in B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), sponsored by Medical College of Wisconsin. Started Jun 2022; status: terminated.
02
Drugs
CAR20.19.22
03
Conditions
B-cell non-Hodgkin lymphomachronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT05094206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05094206.